Chemotherapy With Rituximab for Aggressive B-NHL in Children and Adolescents

Clinical trial NCT07168980 · RECRUITING

Trial details

NCT number: NCT07168980
Sponsor: Children's Cancer Group, China
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Mature B-cell Non-Hodgkin Lymphoma

Start date: 2025-07-01
Primary completion: 2030-06-30
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.